Glenn T Konopaske1, Sivan Subburaju2, Joseph T Coyle2, Francine M Benes2. 1. Mailman Research Center, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: gkonopaske@mclean.harvard.edu. 2. Mailman Research Center, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: We previously observed dendritic spine loss in the dorsolateral prefrontal cortex (DLPFC) from schizophrenia and bipolar disorder subjects. In the current study, we sought to determine if the mRNA expression of genes known to regulate the actin cytoskeleton and spines correlated with spine loss. METHODS: Five candidate genes were identified using previously obtained microarray data from the DLPFC from schizophrenia and control subjects. The relative mRNA expression of the genes linked to dendritic spine growth and function, i.e. IGF1R, MARCKS, PPP1R9A, PTPRF, and ARHGEF2, was assessed using quantitative real-time PCR (qRT-PCR) in the DLPFC from a second cohort including schizophrenia, bipolar disorder, and control subjects. Functional pathway analysis was conducted to determine which actin cytoskeleton-regulatory pathways the genes of interest interact with. RESULTS: MARCKS mRNA expression was increased in both schizophrenia and bipolar disorder subjects. PPP1R9A mRNA expression was increased in bipolar disorder subjects. For IGF1R, mRNA expression did not differ significantly among groups; however, it did show a significant, negative correlation with dendrite length. MARCKS and PPP1R9A mRNA expression did not correlate with spine loss, but they interact with NMDA receptor signaling pathways that regulate the actin cytoskeleton and spines. CONCLUSIONS: MARCKS and PPP1R9A might contribute to spine loss in schizophrenia and bipolar disorder through their interactions, possibly indirect ones, with NMDA signaling pathways that regulate spine structure and function.
BACKGROUND: We previously observed dendritic spine loss in the dorsolateral prefrontal cortex (DLPFC) from schizophrenia and bipolar disorder subjects. In the current study, we sought to determine if the mRNA expression of genes known to regulate the actin cytoskeleton and spines correlated with spine loss. METHODS: Five candidate genes were identified using previously obtained microarray data from the DLPFC from schizophrenia and control subjects. The relative mRNA expression of the genes linked to dendritic spine growth and function, i.e. IGF1R, MARCKS, PPP1R9A, PTPRF, and ARHGEF2, was assessed using quantitative real-time PCR (qRT-PCR) in the DLPFC from a second cohort including schizophrenia, bipolar disorder, and control subjects. Functional pathway analysis was conducted to determine which actin cytoskeleton-regulatory pathways the genes of interest interact with. RESULTS:MARCKS mRNA expression was increased in both schizophrenia and bipolar disorder subjects. PPP1R9A mRNA expression was increased in bipolar disorder subjects. For IGF1R, mRNA expression did not differ significantly among groups; however, it did show a significant, negative correlation with dendrite length. MARCKS and PPP1R9A mRNA expression did not correlate with spine loss, but they interact with NMDA receptor signaling pathways that regulate the actin cytoskeleton and spines. CONCLUSIONS:MARCKS and PPP1R9A might contribute to spine loss in schizophrenia and bipolar disorder through their interactions, possibly indirect ones, with NMDA signaling pathways that regulate spine structure and function.
Authors: Derek Sieburth; QueeLim Ch'ng; Michael Dybbs; Masoud Tavazoie; Scott Kennedy; Duo Wang; Denis Dupuy; Jean-François Rual; David E Hill; Marc Vidal; Gary Ruvkun; Joshua M Kaplan Journal: Nature Date: 2005-07-28 Impact factor: 49.962
Authors: P Billuart; T Bienvenu; N Ronce; V des Portes; M C Vinet; R Zemni; H Roest Crollius; A Carrié; F Fauchereau; M Cherry; S Briault; B Hamel; J P Fryns; C Beldjord; A Kahn; C Moraine; J Chelly Journal: Nature Date: 1998-04-30 Impact factor: 49.962
Authors: D S Manoach; R L Gollub; E S Benson; M M Searl; D C Goff; E Halpern; C B Saper; S L Rauch Journal: Biol Psychiatry Date: 2000-07-15 Impact factor: 13.382
Authors: Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman Journal: Genome Biol Date: 2002-06-18 Impact factor: 13.583
Authors: Glenn T Konopaske; Darrick T Balu; Kendall T Presti; Grace Chan; Francine M Benes; Joseph T Coyle Journal: Schizophr Res Date: 2018-05-11 Impact factor: 4.939
Authors: Maureen A Malloy; Joseph J Kochmanski; Tamara R Jones; Justin A Colacino; Jaclyn M Goodrich; Dana C Dolinoy; Laurie K Svoboda Journal: Front Genet Date: 2019-10-10 Impact factor: 4.599
Authors: Alexander Charles Mott; Andrea Mott; Siegfried Preuß; Jörn Bennewitz; Jens Tetens; Clemens Falker-Gieske Journal: Front Genet Date: 2022-08-17 Impact factor: 4.772
Authors: Mohammed Uddin; Giovanna Pellecchia; Bhooma Thiruvahindrapuram; Lia D'Abate; Daniele Merico; Ada Chan; Mehdi Zarrei; Kristiina Tammimies; Susan Walker; Matthew J Gazzellone; Thomas Nalpathamkalam; Ryan K C Yuen; Koenraad Devriendt; Géraldine Mathonnet; Emmanuelle Lemyre; Sonia Nizard; Mary Shago; Ann M Joseph-George; Abdul Noor; Melissa T Carter; Grace Yoon; Peter Kannu; Frédérique Tihy; Erik C Thorland; Christian R Marshall; Janet A Buchanan; Marsha Speevak; Dimitri J Stavropoulos; Stephen W Scherer Journal: Sci Rep Date: 2016-07-01 Impact factor: 4.379
Authors: Samira S Valvassori; Gustavo C Dal-Pont; Wilson R Resende; Roger B Varela; Bruna R Peterle; Fernanda F Gava; Francielle G Mina; José H Cararo; André F Carvalho; João Quevedo Journal: Int J Neuropsychopharmacol Date: 2017-11-01 Impact factor: 5.176